Skip to content

Kinematic and Neuromuscular Deficiencies Phenotypes Associated With Patellofemoral Pain Syndrome

Kinematic and Neuromuscular Deficiencies Phenotypes Associated With Patellofemoral Pain Syndrome : a Cross-sectional Interventional Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05441332
Acronym
PHENOPAT
Enrollment
45
Registered
2022-07-01
Start date
2022-12-09
Completion date
2025-02-27
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Keywords

Patellofemoral pain syndrome, 3D Kinematics, assessment, clinical phenotypes, dynamic deficiencies

Brief summary

The purpose of this study is to describe and compare the kinematic deficiencies specifically associated with each of the 3 main clinical phenotypes of patellofemoral pain syndrome. The prevalence of patellofemoral pain is high with a high rate of chronicity and recurrence and an overrepresentation of young, athletic and female populations. There are multiple classifications of patellofemoral pain syndrome. A pragmatic classification distinguishes 3 main clinical phenotypes of patellofemoral pain syndrome: with objectively displaceable patella, with extra-patellar alignment problems and without alignment problems. The pathophysiology of patellofemoral pain syndrome is multifactorial involving static and dynamic dysfunctions of the hip, knee and foot, which remain incompletely elucidated to date. The links between the clinical and biomechanical aspects are still unclear and the kinematic and neuromuscular deficiencies associated with the 3 main clinical phenotypes are poorly understood. A validated non-invasive device allows the 3D evaluation of femorotibial rotations during walking.

Detailed description

The diagnostic process is based on clinical examination. The evolution of measuring tools like radios, RMI and kinematics device allows a more precise diagnostic of patellofemoral Pain syndrome. We still don't know what kind of gait parameters could help to categorize the different phenotypes. With a better understanding of these phenotypes the investigators will be able to propose a better personalized rehabilitation. Patellofemoral pain syndrome is defined as an anterior knee pain in front of and around the patella. The diagnosis of patellofemoral pain syndrome is based on clinical examination and standard imaging. The pathophysiology of the patellofemoral pain syndrome is multifactorial involving static and dynamic dysfunctions of the hip, knee and foot, which remain incompletely elucidated to date. The prevalence of patellofemoral pain is high with a high rate of chronicity and recurrence and an overrepresentation of young, athletic and female populations. A pragmatic classification distinguishes 3 main clinical phenotypes of patellofemoral pain syndrome: with objectively displaceable patella, with extra-patellar alignment problems and without alignment problems. The links between the clinic and biomechanics are still unclear and the kinematics and neuromuscular impairments associated with the 3 main clinical phenotypes are poorly understood. The KneeKG is an optoelectronic kinematic assessment device using non-invasive sensors and dedicated to real-time measurement of 3D femoro-tibial position and rotations. The kinematic, neuro-muscular, postural and proprioceptive assessments will allow us to better understand the pathophysiology of the patellofemoral pain syndrome, to establish a more accurate diagnosis of the disease, and provide a better understanding of its causes. Several studies have shown that better adherence to exercise is associated with greater benefit in terms of pain and function in chronic pathologies. Semi-structured interviews will enable the investigators to assess the impact of information derived from kinematic examination of the knees on adherence to treatment.

Interventions

OTHEREOS Radiation

One EOS exam of lower extremities

BEHAVIORALSemi-structured interview

Semi-structured interview to identify factors influencing patient adherence behavior for a sub-group of 15 patients. By phone, between 1 to 3 months after inclusion.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Medical diagnosis of SDFP : * Anterior pain of the knee, mechanical, in front of and around the patella noted at more than 3/10 on a simple numerical scale (ligament or meniscal damage, synovial plicae, tendinopathies, apophysitis, neuromas, and osteoarthritis FT are differential diagnoses), * Pain during any of the following activities: Going up / down stairs, squats, jumps, jogging, sitting, crouching. * Duration of knee anterior pain greater than 1 month * Affiliation to a social insurance * Signature of the consent to participate

Exclusion criteria

* Neurological disorders affecting the lower extremities * Radiographic FT osteoarthritis * History of surgery or trauma to the lower limb less than 1 year old * Intra-articular knee infiltration ≤ 2 months * Cognitive or behavioral problems making it impossible to assess * Participates in intervention research or is in the exclusion period following a previous research, if applicable * Unable to speak, read and write French * Patients under guardianship or curatorship, * Patients receiving AME (French State Medical aid)

Design outcomes

Primary

MeasureTime frameDescription
Amplitude of rotationDay of inclusion (up to 10 days)Amplitude of rotation of the femur with respect to the tibia in the bearing phase in the 3 planes of space

Secondary

MeasureTime frameDescription
Length measuresDay of inclusion (up to 10 days)EOS femoro-tibial alignment
Q angle (in degree)Day of inclusion (up to 10 days)EOS femoro-tibial alignment
Varus valgus(in degree)Day of inclusion (up to 10 days)EOS femoro-tibial alignment
Peak torque (N.m)Day of inclusion (up to 10 days)Quadriceps isokinetic strenght
Total work (N.m)Day of inclusion (up to 10 days)Quadriceps isokinetic strenght
Quadriceps/Hamstring ratio : 2 measure/legDay of inclusion (up to 10 days)
Average torque (N.m)Day of inclusion (up to 10 days)Hip abductors static strenght
Time for reaching peak (s)Day of inclusion (up to 10 days)Hip abductors static strenght
Time difference in the onset between the m.vastus lateralis and m.vastus medialis contraction in msDay of inclusion (up to 10 days)Activity of the quadriceps measured. Electromyogram was used to quantify the electric potential of quadriceps and referred to as 'quadriceps muscle EMG activity' throughout
Y testDay of inclusion (up to 10 days)Static and dynamic unipodal balance
Eccentric step-down testDay of inclusion (up to 10 days)Static and dynamic unipodal balance
Lateral step down testDay of inclusion (up to 10 days)Static and dynamic unipodal balance
Unipodal stabilometric evaluationDay of inclusion (up to 10 days)Static and dynamic unipodal balance
Foot posture indexDay of inclusion (up to 10 days)Foot static
Navicular drop testDay of inclusion (up to 10 days)Foot static
Ober's testDay of inclusion (up to 10 days)Muscle hypoextensibility. Quadriceps, harmstrings, calves,
Visual Analog ScaleDay of inclusion (up to 10 days)Determine pain / No pain = 0, maximal pain =100
Anterior knee pain scale (AKPS)Day of inclusion (up to 10 days)Questionnaire to determine pain / 13 questions, minimum score = 0 point, maximum score = 100 points
12-Item Short Form Survey (SF-12)Day of inclusion (up to 10 days)Quality of life, to determine pain
Semi-structured interviewFrom month 1 to month 3Semi-structured interview for a sub-group of 15 patients identify factors influencing patient adherence behavior.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMarvin COLEMAN, MSc, PhD student

Assistance Publique - Hôpitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026